RE: SP drops on NASDAQ after US26 Oct 2018 08:15
Frustrating though this undoubtedly is, now is very much a holding period. I do not expect much take-up over the next three months as retail and institutional investors wait on the big FDA decision. Expect to be in the c.30p to c.33p through to next year.....it’s all about February 2019 onwards. Then and only then, will we know. It will either tank or we will see how well received a formal approval is. It’s quite possible it does not rise a huge amount without a formal partner agreement announced at the same time or very shortly after. Assuming the latter is a very strong, value add proposition, then in my opinion, we should move up to maybe c.60p. As ever my numbers are always pretty conservative; but, to date, have proven to be 100% correct. Sadly! ATB